Is There a Place for Endobronchial Stent Treatment in Laryngeal Papillomatosis? Case Report and Literature Review

Zinni MA, España MI, Carrabs A and Bustos ME

Department of Thorax Surgery, Private University Hospital of Córdoba, Argentina

^*Correspondance to: Marisol A Zinni 

 PDF  Full Text Case Report | Open Access

Abstract:

Recurrent respiratory papillomatosis is a challenging chronic airway disease that occurs in both children and adults. It is caused by the human papillomavirus, more than 90% caused by HPV types 6 and HPV 11. The clinical presentation is nonspecific and most patients present with hoarseness, stridor or dyspnea. Although there is no definitive treatment for RRP, the objective of treatment focuses on improving voice quality and maintaining airway patency, in our case it was achieved through the placement of a Y-shaped stent placed in airway added to adjuvant treatment with Bevacizumab. Surgical management is the mainstay of treatment and around 20% of patients benefit from adjuvant therapies.

Keywords:

Papillomatosis; Airway; Y-stent

Cite the Article:

Zinni MA, España MI, Carrabs A, Bustos ME. Is There a Place for Endobronchial Stent Treatment in Laryngeal Papillomatosis? Case Report and Literature Review. World J Surg Surgical Res. 2024; 7: 1529..